Search

everythinglearnresearchcommunity

for

Search:↓

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Effective PCOS treatments require targeting specific signaling pathways.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Eruptive vellus hair cysts are a cosmetic skin condition, more common in young adults, with few effective treatments.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.